Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-?1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system
- 21 May 1999
- journal article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 180 (1) , 61-70
- https://doi.org/10.1002/(sici)1097-4652(199907)180:1<61::aid-jcp7>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Fibrogenic and anti-fibrogenic factors in wound repairPublished by Elsevier ,1996
- Targeting TGF–β for treatment of diseaseNature Medicine, 1995
- Fibrosis linked to TGF-beta in yet another disease.Journal of Clinical Investigation, 1995
- Expression of mRNA for Transforming Growth Factor-β1 Is Reduced in Hypertrophic Scar and Normal Dermal Fibroblasts Following Serial Passage In VitroJournal of Investigative Dermatology, 1994
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor β1Journal of Immunological Methods, 1993
- Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.Proceedings of the National Academy of Sciences, 1991
- Uterine Insulin-Like Growth Factor-I Receptors: Regulation by Estrogen and Variation throughout the Estrous Cycle*Endocrinology, 1989
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in cultureJournal of Cellular Physiology, 1989
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979